Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026
Same author

Second Joint Annual Congress of the British Society of Toxicologic Pathology and the European Society of Toxicologic Pathology Special Issue.

Toxicologic pathology·2026
Same author

Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer.

Nature communications·2026
Same author

Nucleophagy removes cytotoxic trapped PARP1.

Nature cell biology·2026
Same author

Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.

Nature cancer·2026
Same author

FAP-Targeted LTBR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumours.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Comparison of Standard Clinical Pathology Parameter Values in Fasted and Fed Rats and Non-human Primates.

Toxicologic pathology·2026
Same journal

Time-Dependent Autolysis in Ex Vivo-Maintained Rat Tissue in Saline: A Descriptive Study and Practical Guidance for Histopathologic Assessment.

Toxicologic pathology·2026
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

4.8K

Mini Review: Spatial Transcriptomics to Decode the Central Nervous System.

Benedek Pesti1,2, Xavi Langa1, Nadine Kumpesa1

  • 1Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Toxicologic Pathology
|March 22, 2025
PubMed
Summary
This summary is machine-generated.

Spatial transcriptomics (ST) maps gene expression in the central nervous system (CNS). This technology aids neurodegenerative disease research by revealing molecular mechanisms and potential drug targets.

Keywords:
Alzheimer’s diseaseParkinson’s diseaseamyotrophic lateral sclerosiscentral nervous systemmultiple sclerosisneurodegenerative diseasesspatial transcriptomics

More Related Videos

Spatially Compact Arrangement of Larval Zebrafish Sections for Spatial Transcriptomic Analysis
07:40

Spatially Compact Arrangement of Larval Zebrafish Sections for Spatial Transcriptomic Analysis

Published on: May 16, 2025

49
Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
09:49

Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing

Published on: December 3, 2019

10.7K

Related Experiment Videos

Last Updated: May 21, 2025

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

4.8K
Spatially Compact Arrangement of Larval Zebrafish Sections for Spatial Transcriptomic Analysis
07:40

Spatially Compact Arrangement of Larval Zebrafish Sections for Spatial Transcriptomic Analysis

Published on: May 16, 2025

49
Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
09:49

Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing

Published on: December 3, 2019

10.7K

Area of Science:

  • Neuroscience
  • Genomics
  • Biotechnology

Background:

  • Spatial transcriptomics (ST) provides spatially resolved gene expression data, revolutionizing central nervous system (CNS) research.
  • Neurodegenerative diseases like Alzheimer's, Parkinson's, multiple sclerosis, and ALS are complex and benefit from advanced molecular mapping.

Purpose of the Study:

  • To review the impact and applications of spatial transcriptomics in understanding CNS disorders.
  • To highlight how ST advances the study of neurodegenerative diseases by integrating gene expression with tissue architecture.

Main Methods:

  • Review of foundational sequencing-based and imaging-based spatial transcriptomics techniques.
  • Analysis of key studies demonstrating ST's utility in mapping transcriptomes to histomorphology and elucidating disease mechanisms.

Main Results:

  • ST enables mapping of gene expression to specific tissue structures and cellular vulnerabilities in CNS diseases.
  • Integration of single-cell data with tissue-level mapping and identification of receptor-ligand interactions are key applications.
  • ST facilitates understanding of regional and cellular susceptibility in neurodegeneration.

Conclusions:

  • Spatial transcriptomics offers powerful insights into the molecular underpinnings of neurodegenerative diseases.
  • ST aids in identifying novel drug targets and evaluating therapeutic strategies for CNS disorders.
  • This technology bridges the gap between animal models and human studies for developing effective CNS treatments.